Trial
NCT00848328
Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
Celgene
Condition
Lymphoma
Intervention
Rituximab
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-24